MedTrace Logo

Hemochromatosis and Iron Overload Screening Study (HEIRS)

NCT00005541 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-04-14

No results posted yet for this study

Summary

To determine the prevalence, genetic and environmental determinants, and potential clinical, personal, and societal impact of iron overload and hereditary hemochromatosis, in a multi-center, multiethnic, primary care-based sample of 100,000 adults. The study is conducted by the Division of Epidemiology and Clinical Applications of the NHLBI, the Division of Blood Diseases and Resources of the NHLBI, and the Ethical, Legal, and Social Implications (ELSI) Research Program of the NHGRI.

Conditions

  • Blood Disease
  • Hemochromatosis
  • Iron Overload

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Ronald Acton · University of Alabama at Birmingham

  • Paul Adams · London Health Sciences Centre

  • John Eckfeldt · University of Minnesota

  • Victor Gordeuk · Howard University

  • Emily Harris · Kaiser Foundation Research Institute

  • Christine McLaren · University of California

  • David Reboussin · Wake Forest University

Eligibility

Min Age
25 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2006-01-31
Completion
2006-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005541 on ClinicalTrials.gov